These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28591094)

  • 1. Non-clear cell renal cell carcinomas: biological insights and therapeutic challenges and opportunities.
    Malouf GG; Joseph RW; Shah AY; Tannir NM
    Clin Adv Hematol Oncol; 2017 May; 15(5):409-418. PubMed ID: 28591094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Atypical Renal Cell Carcinomas.
    Liaw BC; Mehrazin R; Baker C; Sfakianos JP; Tsao CK
    Curr Treat Options Oncol; 2017 Sep; 18(10):61. PubMed ID: 28913767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Therapy Options in Renal Cell Carcinoma: Where Do We Stand?
    Martinez Chanza N; Tripathi A; Harshman LC
    Curr Treat Options Oncol; 2019 May; 20(5):44. PubMed ID: 31054006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collecting ducts carcinoma: An orphan disease. Literature overview and future perspectives.
    Pagani F; Colecchia M; Sepe P; Apollonio G; Claps M; Verzoni E; de Braud F; Procopio G
    Cancer Treat Rev; 2019 Sep; 79():101891. PubMed ID: 31491662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options.
    Ahrens M; Scheich S; Hartmann A; Bergmann L;
    Oncol Res Treat; 2019; 42(3):128-135. PubMed ID: 30799404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary management of advanced renal cell carcinoma.
    Khanna A; Crane A; Yerram N; Sun D; Ericson K; Lundy SD; Abouassaly R
    Clin Adv Hematol Oncol; 2018 Jun; 16(6):438-446. PubMed ID: 30067615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal Cell Carcinoma of Variant Histology: Biology and Therapies.
    Msaouel P; Genovese G; Tannir NM
    Hematol Oncol Clin North Am; 2023 Oct; 37(5):977-992. PubMed ID: 37244822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Therapies for the Management of Non-Clear Cell Renal Cell Carcinoma: What Works, What Doesn't, and What the Future Holds.
    Zoumpourlis P; Genovese G; Tannir NM; Msaouel P
    Clin Genitourin Cancer; 2021 Apr; 19(2):103-116. PubMed ID: 33358151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced treatments in non-clear renal cell carcinoma.
    Tazi el M; Essadi I; Tazi MF; Ahellal Y; M'rabti H; Errihani H
    Urol J; 2011; 8(1):1-11. PubMed ID: 21404194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New therapeutic opportunities in metastatic renal cell carcinoma].
    Buess M
    Praxis (Bern 1994); 2009 Apr; 98(9):481-6. PubMed ID: 19404907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology.
    Motzer RJ; Bacik J; Mariani T; Russo P; Mazumdar M; Reuter V
    J Clin Oncol; 2002 May; 20(9):2376-81. PubMed ID: 11981011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary Renal Cell Carcinoma: A Review of Prospective Clinical Trials.
    Maughan BL; Sirohi D
    Curr Treat Options Oncol; 2023 Sep; 24(9):1199-1212. PubMed ID: 37407886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for the Management of Rare Kidney Cancers.
    Giles RH; Choueiri TK; Heng DY; Albiges L; Hsieh JJ; Linehan WM; Pal S; Maskens D; Paseman B; Jonasch E; Malouf G; Molina AM; Pickering L; Shuch B; Srinivas S; Srinivasan R; Tannir NM; Bex A
    Eur Urol; 2017 Dec; 72(6):974-983. PubMed ID: 28720391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature.
    John A; Spain L; Hamid AA
    Curr Oncol; 2023 Jan; 30(1):923-937. PubMed ID: 36661719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
    Shioi K; Komiya A; Hattori K; Huang Y; Sano F; Murakami T; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
    Clin Cancer Res; 2006 Dec; 12(24):7339-46. PubMed ID: 17189405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options.
    Wilson NR; Acikgoz Y; Hasanov E
    Int J Cancer; 2024 Mar; 154(6):947-961. PubMed ID: 37823185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant treatment for renal cell carcinoma: do we finally have a major breakthrough?
    Patel DN; Figlin RA; Kim HL
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):907-914. PubMed ID: 27930642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
    Goebell PJ; Ivanyi P; Bedke J; Bergmann L; Berthold D; Boegemann M; Busch J; Doehn C; Krege S; Retz M; Amsberg GV; Grimm MO; Gruenwald V
    Future Oncol; 2020 Oct; 16(29):2307-2328. PubMed ID: 32964728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on First-Line Combination Treatment Approaches in Metastatic Clear-Cell Renal Cell Carcinoma.
    Christensen BR; Hajja YM; Koshkin V; Barata PC
    Curr Treat Options Oncol; 2021 Jan; 22(2):15. PubMed ID: 33438115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating Immunotherapy Into the Management of Renal Cell Carcinoma.
    Zibelman M; Plimack ER
    J Natl Compr Canc Netw; 2017 Jun; 15(6):841-847. PubMed ID: 28596263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.